熱門資訊> 正文
Purple Biotech宣布收到纳斯达克最低出价通知
2025-10-21 04:08
- Purple Biotech Ltd (NASDAQ:PPBT) said on Monday it received a notice from Nasdaq that its American Depositary Shares (ADSs) have been below the $1 minimum bid price required for continued listing for 30 consecutive trading days.
- The company has 180 days, until April 14, 2026, to regain compliance by maintaining a closing price of $1 or more for ten consecutive business days.
- If unsuccessful, Nasdaq may grant an additional 180-day cure period, subject to other listing requirements.
- Trading of PPBT ADSs will continue during the compliance period.
- PPBT closed -5.24% at $0.576.
- Source: Press Release
More on Purple Biotech
- Purple Biotech prices $6M public offering, $12M potential via warrants; shares down
- Seeking Alpha’s Quant Rating on Purple Biotech
- Historical earnings data for Purple Biotech
- Financial information for Purple Biotech
推薦文章
美股機會日報 | 金價再度走弱！現失守4030美元；中美貿易爭端緩和，納指期貨漲超1%
IBM、AMD雙雙大漲近8%！量子計算概念再起飛，下一個贏家是誰？
新股暗盤 | 滴普科技漲近50%，中籤一手賬面浮盈2660港元
新股暗盤 | 八馬茶業漲79.00%，中籤一手賬面浮盈3950港元
美股波動中的穩健長跑選手：華爾街押注Pinterest(PINS.US)、Uber(UBER.US)與通用汽車(GM.US)
黃金火爆行情帶熱招聘市場 對衝基金、貿易商高薪爭奪交易人才
迷霧中前行！美聯儲本周料將再度降息 內部分歧恐進一步加劇？
新股申購 | 「首家A+H豪華新能源車企」賽力斯今起招股，一手入場費13282.62港元
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
